» Articles » PMID: 23665170

Structure of Rhomboid Protease in Complex with β-lactam Inhibitors Defines the S2' Cavity

Overview
Journal Structure
Publisher Cell Press
Date 2013 May 14
PMID 23665170
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Rhomboids are evolutionarily conserved serine proteases that cleave transmembrane proteins within the membrane. The increasing number of known rhomboid functions in prokaryotes and eukaryotes makes them attractive drug targets. Here, we describe structures of the Escherichia coli rhomboid GlpG in complex with β-lactam inhibitors. The inhibitors form a single bond to the catalytic serine and the carbonyl oxygen of the inhibitor faces away from the oxyanion hole. The hydrophobic N-substituent of β-lactam inhibitors points into a cavity within the enzyme, providing a structural explanation for the specificity of β-lactams on rhomboid proteases. This same cavity probably represents the S2' substrate binding site of GlpG. We suggest that the structural changes in β-lactam inhibitor binding reflect the state of the enzyme at an initial stage of substrate binding to the active site. The structural insights from these enzyme-inhibitor complexes provide a starting point for structure-based design for rhomboid inhibitors.

Citing Articles

4-Oxo-β-lactams as Covalent Inhibitors of the Mitochondrial Intramembrane Protease PARL.

Ji S, Bach K, Miriyala V, Dohnalek J, Riopedre-Fernandez M, Lepsik M ACS Med Chem Lett. 2024; 15(12):2101-2106.

PMID: 39691509 PMC: 11647676. DOI: 10.1021/acsmedchemlett.4c00384.


The opening dynamics of the lateral gate regulates the activity of rhomboid proteases.

Bohg C, Oster C, Turkaydin B, Lisurek M, Sanchez-Carranza P, Lange S Sci Adv. 2023; 9(29):eadh3858.

PMID: 37467320 PMC: 10355837. DOI: 10.1126/sciadv.adh3858.


Rapid synthesis of internal peptidyl α-ketoamides by on resin oxidation for the construction of rhomboid protease inhibitors.

Van Kersavond T, Konopatzki R, van der Plassche M, Yang J, Verhelst S RSC Adv. 2022; 11(7):4196-4199.

PMID: 35424368 PMC: 8694341. DOI: 10.1039/d0ra10614c.


A combination of solid-state NMR and MD simulations reveals the binding mode of a rhomboid protease inhibitor.

Bohg C, Oster C, Utesch T, Bischoff S, Lange S, Shi C Chem Sci. 2021; 12(38):12754-12762.

PMID: 34703562 PMC: 8494044. DOI: 10.1039/d1sc02146j.


The rhomboid protease GlpG has weak interaction energies in its active site hydrogen bond network.

Gaffney K, Hong H J Gen Physiol. 2018; 151(3):282-291.

PMID: 30420443 PMC: 6400518. DOI: 10.1085/jgp.201812047.


References
1.
Urban S, Wolfe M . Reconstitution of intramembrane proteolysis in vitro reveals that pure rhomboid is sufficient for catalysis and specificity. Proc Natl Acad Sci U S A. 2005; 102(6):1883-8. PMC: 548546. DOI: 10.1073/pnas.0408306102. View

2.
Xue Y, Chowdhury S, Liu X, Akiyama Y, Ellman J, Ha Y . Conformational change in rhomboid protease GlpG induced by inhibitor binding to its S' subsites. Biochemistry. 2012; 51(18):3723-31. PMC: 3351039. DOI: 10.1021/bi300368b. View

3.
Doherty J, Ashe B, Argenbright L, Barker P, Bonney R, Chandler G . Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase. Nature. 1986; 322(6075):192-4. DOI: 10.1038/322192a0. View

4.
Pierrat O, Strisovsky K, Christova Y, Large J, Ansell K, Bouloc N . Monocyclic β-lactams are selective, mechanism-based inhibitors of rhomboid intramembrane proteases. ACS Chem Biol. 2010; 6(4):325-35. PMC: 3077804. DOI: 10.1021/cb100314y. View

5.
Ben-Shem A, Fass D, Bibi E . Structural basis for intramembrane proteolysis by rhomboid serine proteases. Proc Natl Acad Sci U S A. 2006; 104(2):462-6. PMC: 1766407. DOI: 10.1073/pnas.0609773104. View